Re: EOP2A experience?

On 10 August 2010 16:32, <[email protected]> wrote: > > Dear All, > > I am interested on the FDA guidance about End of Phase 2 A (EOP2A) > meetings. Some of you certainly have participated > into the preparation or have attended such meeting (during the pilot phase > or after) and have real life experience. If so, it would be much apreciated > if you could share some of this experience. Thank you in advance for your > replies. > > Kind regards, > > Pascal Girard > This message and any attachment are confidential and may be privileged or > otherwise protected from disclosure. If you are not the intended recipient, > you must not copy this message or attachment or disclose the contents to any > other person. If you have received this transmission in error, please notify > the sender immediately and delete the message and any attachment from your > system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not > accept liability for any omissions or errors in this message which may arise > as a result of E-Mail-transmission or for damages resulting from any > unauthorized changes of the content of this message and any attachment > thereto. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not > guarantee that this message is free of viruses and does not accept liability > for any damages caused by any virus transmitted therewith. > > Click * http://disclaimer.merck.de* to access the German, French, Spanish > and Portuguese versions of this disclaimer.